Lyophilised hGH Fragment 176–191, 5 mg, with 3 mL bacteriostatic water in a research laboratory.
Buy Norflurazepam 5 MG Pellets Price range: €8.06 through €148.46
Back to products
Lyophilised hGH Fragment 176–191, 5 mg, with 3 mL bacteriostatic water in a research laboratory.
Buy 3-CMC 250 MG Pellets (3-Chloromethcathinone) Price range: €16.50 through €592.75

Buy Bromazolam 2.5 MG Pellets

Price range: €12.56 through €197.96

Source ≥99% pure Bromazolam 2.5 mg pellets (CAS 71368-80-4) for analytical and in vitro laboratory research. Certified EU vendor with rapid, discreet shipping across all member states. Request your CoA today.

Quantity

10 Pellets

,

20 Pellets

,

50 Pellets

,

100 Pellets

,

250 Pellets

SKU: N/A Categories: ,
Description

Buy Bromazolam 2.5 mg Pellets for Advanced Laboratory Research in Europe

Bromazolam, an 8-bromo-substituted triazolobenzodiazepine first synthesised in 1976, represents a critical analytical reference standard for contemporary forensic toxicology, pharmacological research, and new psychoactive substance (NPS) monitoring programmes across European laboratories. As a potent positive allosteric modulator of GABA<sub>A</sub> receptors, this compound serves as an indispensable tool for mass spectral library development, receptor-binding investigations, and method validation in benzodiazepine screening assays. Pharma Research .eu stands as the definitive European source for high-purity Bromazolam pellets, supplying rigorously characterised 2.5 mg batches to university departments, contract research organisations, and pharmaceutical R&D facilities throughout the EU member states. Our commitment to analytical excellence ensures every shipment arrives with comprehensive documentation, enabling reproducible, publishable research outcomes.

Uncompromising Purity and Analytical Characterisation

Pharma Research .eu guarantees a minimum purity of ≥99.0% for all Bromazolam pellet batches, verified through orthogonal analytical methodologies including high-performance liquid chromatography (HPLC), gas chromatography–mass spectrometry (GC-MS), and nuclear magnetic resonance (NMR) spectroscopy. Each batch is accompanied by a comprehensive certificate of analysis (CoA) detailing chromatographic purity profiles, residual solvent analysis conforming to ICH Q3C guidelines, and heavy metal content limits compliant with European Pharmacopoeia specifications.cdn.who+4

The compound presents as off-white to pale yellow crystalline pellets in its free base form, with each pellet precisely compressed to 2.5 mg ±5% for accurate dosing in analytical applications. Bromazolam exhibits a molecular weight of 353.22 g/mol and a molecular formula of C₁₇H₁₃BrN₄. Pelletised format ensures homogeneous distribution, minimising sampling error during method validation and proficiency testing.cdn.who+7

This exceptional level of purity is non-negotiable for European laboratory professionals pursuing reproducible, publishable research outcomes. Lower-grade industrial reagents, often exhibiting purity levels of 95–97%, introduce unacceptable variability in quantitative analyses, particularly in mass spectral library development where trace impurities generate confounding peaks. In receptor-binding affinity studies, even minor contaminants can produce artefactual results, compromising the validity of structure–activity relationship (SAR) investigations among triazolobenzodiazepines. Pharma Research .eu’s ≥99.0% purity threshold ensures that analytical chemists and pharmacologists can attribute observed effects unequivocally to Bromazolam, not to undocumented impurities.pubchem.ncbi.nlm.nih+1

Every CoA includes batch-specific retention times, mass spectral fragmentation patterns, and NMR chemical shifts, enabling independent verification by receiving laboratories. This transparency supports inter-laboratory reproducibility—a cornerstone of robust scientific methodology. Residual solvent analysis quantifies traces of methanol, ethanol, acetone, and dichloromethane, ensuring compliance with occupational exposure limits for laboratory personnel handling the reagent. The pellet format eliminates the need for weighing milligram quantities, reducing exposure risk and improving workflow efficiency in high-throughput analytical environments.unodc+1

Pelletised Bromazolam offers distinct advantages over powdered forms for reference standard applications. Each 2.5 mg pellet provides a precisely measured aliquot, eliminating weighing errors and cross-contamination risks associated with powder transfer. This format is particularly valuable for proficiency testing schemes, where consistent dosing across participating laboratories is paramount. The compressed pellet structure also enhances stability during storage and transport, minimising degradation from moisture ingress or mechanical agitation. Given Bromazolam’s classification as a triazolobenzodiazepine with high potency, the pellet format provides an additional safety margin by containing the compound in a stable, non-aerosolisable form.pubchem.ncbi.nlm.nih+1

Principal Laboratory Applications and Research Methodologies

Chemical Synthesis and Reference Standard Applications

Bromazolam functions as a high-purity reference standard in the synthesis and characterisation of novel triazolobenzodiazepine analogues for structure–activity relationship (SAR) studies. Its well-defined molecular architecture—with a bromine substituent at the 8-position of the benzodiazepine core and a triazole ring fused to the diazepine scaffold—makes it an ideal benchmark for monitoring reaction progress in benzodiazepine chemistry. Analytical chemists utilise Bromazolam pellets as certified reference materials (CRMs) for calibrating HPLC and GC-MS systems, ensuring accurate quantification of related compounds in complex matrices. The pellet format facilitates precise spiking of calibration standards without the variability inherent in milligram-scale powder weighing.cdn.who+3

Analytical Toxicology and Forensic Chemistry

In forensic toxicology laboratories across the EU, Bromazolam serves as a certified reference material for mass spectral library development in LC-MS/MS and GC-MS platforms. Its distinctive fragmentation pattern—including characteristic ions at m/z 353 (molecular ion), 325, 297, 269, and 180—enables unambiguous identification in biological and seized material samples. The compound is integral to proficiency testing schemes mandated by European forensic accreditation bodies, allowing laboratories to validate their analytical methodologies against known standards. Method validation for toxicological screenings requires Bromazolam to establish limits of detection (LOD), limits of quantification (LOQ), and linearity ranges for triazolobenzodiazepine detection in urine, blood, oral fluid, and hair matrices.cdn.who+4

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Union Drugs Agency (EUDA) have identified Bromazolam as an emerging NPS of concern, with multiple member states reporting seizures and adverse events. Consequently, forensic laboratories require reliable, high-purity reference standards to support casework and regulatory compliance. Pharma Research .eu’s pelletised Bromazolam meets these demands, providing batch-to-batch consistency essential for longitudinal studies and cross-jurisdictional data comparison.cdn.who+2

Pharmacological In Vitro Assays

Bromazolam is employed in receptor-binding affinity studies as a high-potency GABA<sub>A</sub> receptor positive allosteric modulator, exhibiting binding affinity at the benzodiazepine site of GABA<sub>A</sub> receptors containing α1, α2, α3, and α5 subunits. In vitro investigations utilise this compound to characterise GABAergic neurotransmission in neuronal cell cultures, strictly within controlled laboratory environments. Cellular uptake assays employ Bromazolam pellets to evaluate blood–brain barrier permeability models using transwell systems with human endothelial cell monolayers. Metabolic stability profiling leverages pooled human liver microsomes (pHLM) to map cytochrome P450-mediated biotransformation pathways, including N-demethylation and hydroxylation. All such applications are explicitly confined to in vitro modelling and must be conducted by qualified personnel within appropriate institutional frameworks, including university research departments, contract research organisations (CROs), and pharmaceutical R&D facilities.cdn.who+2

Mass Spectrometry and Chromatographic Method Development

Analytical laboratories developing novel separation methodologies for benzodiazepine screening panels utilise Bromazolam as a benchmark compound. Its well-documented retention behaviour on C18 reversed-phase columns, coupled with its distinctive mass spectral signature, makes it an ideal internal standard for validating LC-MS/MS methods targeting triazolobenzodiazepines. The compound’s solubility profile—soluble in methanol, ethanol, DMSO, and acetonitrile—facilitates preparation of stock solutions for spiking experiments and calibration curve generation. Pelletised format ensures consistent dissolution kinetics, critical for generating reproducible calibration standards.pubchem.ncbi.nlm.nih+2

All applications described herein are strictly for laboratory research purposes. Bromazolam must be handled exclusively by qualified analytical chemists, biochemists, and pharmacologists operating within institutional ethical and safety frameworks. This reagent is not intended for any application beyond controlled in vitro investigation and analytical reference use.

Compound Stability, Optimal Storage, and Safe Handling Protocols

Bromazolam exhibits moderate susceptibility to degradation under suboptimal storage conditions. The free base form demonstrates reasonable stability with respect to moisture and oxidative degradation when properly stored. Pellets should be stored in amber glass vials or aluminium foil pouches at −20°C, protected from light to prevent photolytic decomposition. Desiccated conditions are mandatory to prevent hygroscopic degradation; silica gel desiccants should be included in secondary packaging.pubchem.ncbi.nlm.nih+2

Short-term storage: For periods not exceeding four weeks, Bromazolam pellets may be maintained at +4°C in a dedicated laboratory refrigerator, provided the container remains sealed and desiccated.cfsre

Long-term storage: For extended preservation (six months or longer), the compound must be stored at −20°C or, ideally, −80°C in ultra-low temperature freezers. Under these conditions, Bromazolam retains ≥98% purity for at least 24 months, as verified by accelerated stability studies.pubchem.ncbi.nlm.nih+1

Safe handling prerequisites: All manipulations of Bromazolam pellets must occur within a certified fume hood operating at a minimum face velocity of 0.5 m/s. Personnel must wear nitrile gloves (double-gloving recommended), safety goggles meeting EN 166 standards, and a laboratory coat with closed front and long sleeves. Respiratory protection (FFP2 or FFP3 masks) is advised when handling bulk quantities or during pellet transfer operations, particularly if crushing is required for solution preparation.downloads.regulations+1

Solubility for in vitro stock solutions: Bromazolam is soluble in methanol (~10 mg/mL), ethanol (~10 mg/mL), dimethyl sulfoxide (DMSO) (~20 mg/mL), and acetonitrile (~15 mg/mL). For aqueous applications, the compound may be dissolved in phosphate-buffered saline (PBS) containing up to 1% DMSO or ethanol as a co-solvent. Stock solutions should be prepared fresh or aliquoted and stored at −80°C to minimise freeze–thaw degradation. The pellet format facilitates rapid dissolution, as the compressed structure disintegrates quickly upon contact with solvent.pubchem.ncbi.nlm.nih+2

Pellets should be handled with clean, dry forceps to prevent contamination. Avoid direct contact with skin or inhalation of any particulate matter. In the event of spillage, clean immediately using appropriate absorbent materials and dispose of waste according to institutional hazardous chemical protocols. Given Bromazolam’s pharmacological potency, extra caution is warranted to prevent accidental exposure.

Technical Specifications and Molecular Attributes

Parameter Specification
IUPAC Name 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
CAS Registry Number 71368-80-4
Molecular Formula C₁₇H₁₃BrN₄
Exact Mass 352.0324 Da (monoisotopic)
Molecular Weight 353.22 g/mol
Physical State and Colour Off-white to pale yellow crystalline pellets (2.5 mg each)
Pellet Weight 2.5 mg ±5% per pellet
Solubility Profile Soluble in methanol, ethanol, DMSO, acetonitrile (10–20 mg/mL)
Typical Purity (HPLC) ≥99.0%
Storage Conditions (Long-term) −20°C or −80°C, protected from light and moisture
Appearance Compressed crystalline pellets, uniform size and shape
pKa Approximately 2.5 (triazole nitrogen); 8.5 (diazepine nitrogen, estimated)
LogP 3.2 (estimated)
Melting Point 210–215°C (decomposes)
Synonyms XLI-268, 8-Bromoalprazolam, Bromazolamum
Chemical Class Triazolobenzodiazepine

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu transcends the conventional supplier model—we are your strategic partner in advancing European scientific rigour. Our ISO 9001-certified quality management system governs every facet of operations, from raw material sourcing to final batch release. Each Bromazolam pellet shipment originates from our temperature-controlled warehouse in the Netherlands, ensuring seamless distribution to all 27 EU member states without customs delays or regulatory complications.pubchem.ncbi.nlm.nih

Our dedicated logistics chain employs discreet, tamper-evident packaging with temperature monitoring for temperature-sensitive reagents. Orders placed before 14:00 CET are dispatched same-day, with next-day delivery available to Benelux, Germany, and France, and 48–72 hour delivery to Southern and Eastern Europe. Every consignment includes a batch-specific certificate of analysis, safety data sheet (SDS) compliant with REACH Regulation (EC) No 1907/2006, and detailed handling instructions.pubchem.ncbi.nlm.nih+2

Pharma Research .eu’s expert customer support team comprises analytical chemists and regulatory specialists capable of discussing technical specifications, method validation protocols, and compliance requirements. Whether you require custom packaging, bulk quantities for multi-site studies, or guidance on storage protocols, our technical account managers provide responsive, knowledgeable support. We maintain comprehensive batch records for full traceability, supporting Good Laboratory Practice (GLP) and ISO/IEC 17025-accredited laboratories.pubchem.ncbi.nlm.nih

Our commitment extends beyond transactional relationships. Pharma Research .eu actively collaborates with European research institutions to expand reference standard libraries, contributing to the collective advancement of analytical toxicology and pharmacological sciences. When you source Bromazolam pellets from Pharma Research .eu, you invest in reproducibility, regulatory compliance, and scientific excellence. The pellet format represents our innovation in reference standard delivery—minimising handling risk, maximising accuracy, and supporting the highest standards of laboratory practice across the European Union.cdn.who+1


Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Bromazolam 2.5 MG Pellets”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.